Up to this point, I have been writing a weekly column for the Myeloma Beacon.

Here is a LINK to a story the Myeloma Beacon ran late last week about a European study, featuring an existing cancer drug, bendamustine (trade name:  Treanda).

My Editor at the Myeloma Beacon, Julie Shilane, wrote an excellent article Friday about a very new and experimental leukemia treatment which hit the mainstream news last week.

I saved a link back to this Myeloma Beacon story about new ways to measure a multiple myeloma patient’s complete response.

I think it is understandable I have been featuring a lot of stem cell transplant (SCT) related news and info lately.  So has the Myeloma Beacon.

If you have been reading my blog at all the past few weeks, you already know I have been suffering from a sudden, serious case of peripheral neuropathy (PN).

The Myeloma Beacon just ran a story about the long-term transplant follow-up study I featured this morning.  Great minds must think alike!

In case you missed it, Saturday the Myeloma Beacon ran a summary of important data released from the International Myeloma Workshop in Paris earlier this month.

The Myeloma Beacon continued its ongoing series Friday with a look at a variety of multiple myeloma vaccines currently being studied:

It may not quite be ready for prime time, but I launched my new, multiple myeloma news site today:
Myeloma News.com
Why another myeloma related site?  Simple.

I wrote an article you may want to check-out on today’s Help With Cancer.org site: 
Buyer Beware When Purchasing Vitamins & Nutritional Supplements.

My friend and editor at The Myeloma Beacon, Julie Shilane, did a wonderful job covering ASH this year.  Read her articles for a complete run down of each day’s myeloma related meetings:

Happy Thanksgiving! As many of you may already know, I write a weekly column in the Myeloma Beacon every Thursday—today!

Yesterday morning I wrote an article about how the FDA had approved denosumab (Xgeva) for use in some cancers, but not multiple myeloma.  The Myeloma Beacon also published a story about denosumab later yesterday evening:

Thomas, a good e-mail friend from Germany, forwarded me information about a new, possibly revolutionary anti-myeloma Heat Shock Inhibitor this week.  Here are some links about this new therapy,  PU-H71:

As promised, here are more helpful and uplifting tips from our fellow multiple myeloma patients:

Ted was kind enough to pass along a list with 13 great suggestions:

This week’s column in The Myeloma Beacon,  Pat’s Place: Suggestions From Multiple Myeloma Patients To Help Us All Stay Positive 
is up and running.  Watch for a follow-up article tomorrow with lots more tips about staying positive from our fellow patients and caregivers.

A fellow multiple myeloma patient and guest columnist at The Myeloma Beacon, Sean Murray,  e-mailed me a number of great suggestions for staying positive while facing myeloma and the pain and hassles we all endure.  I wanted to share Sean’s thoughts with you here today:

My column this week in The Myeloma Beacon will feature tips on staying positive when faced with treatment side-effects.  Any tips/suggestions from my readers you would like to see included in my column?  It will run Thursday.

Here is the first part of a story which ran Wednesday in The Myeloma Beacon: